| HGNC approved symbol | SF3B1 |
| HGNC ID | HGNC:10768 |
| HGNC approved name | splicing factor 3b, subunit 1, 155kDa |
| Entrez gene ID | GeneID:23451 (SSTAR profile) |
| UniProt AC (human) | O75533 |
| UniProt ID (human) | SF3B1_HUMAN |
| Pfam domains | SF3b1 PF08920 (327-453) domain PF22646 (1086-1158) |
| MGI symbol | Sf3b1 |
| MGI ID | MGI:1932339 |
| UniProt AC (mouse) | Q99NB9 |
| UniProt ID (mouse) | SF3B1_MOUSE |
| HGNC gene family tag | # |
| HGNC gene family description | # |
| Function | RNA modification |
| Modification | # |
| PMID for information on function | PMID:23568491 |
| Protein complex | B-WICH |
| Target molecule | RNA |
| Target entity | # |
| Product | # |
| PMID for information on target | PMID:23568491 |
| Comment | Although the causative link between SF3B1 mutation and CLL pathogenesis remains unclear, several lines of evidence suggest SF3B1 mutation might be linked to genomic stability and epigenetic modification. |
| Status of entry | # |
| Expression range: | 3.59 to 1017.34 |
| Mean expression: | 150.23 ± 100.24 |
| Median expression: | 128.47 |